Novel treatment of hemophilia: OMRF enters license agreement with Shanghai RAAS Blood Products

World News: . []

OKLAHOMA CITY Feb 13 2018 GLOBE NEWSWIRE -- The Oklahoma Medical Research Foundation has entered a license agreement with Shanghai RAAS Blood Products Co Ltd Under the agreement Shanghai RAAS has the exclusive rights to develop and market novel ...

More news and information about Oklahoma Medical Research Foundation

Published By:

Globe Newswire: 20:02 GMT Tuesday 13th February 2018

Published: .

Search for other references to "novel" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us